Serina Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Serina Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2024.
  • Serina Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was -$2.78M, a 443% decline year-over-year.
  • Serina Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $5.84M, a 30.4% decline year-over-year.
  • Serina Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $5.84M, a 30.4% decline from 2023.
  • Serina Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $8.4M.
  • Serina Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.55M, a 447% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.84M -$2.56M -30.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $8.4M +$11.9M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 -$3.55M -$2.9M -447% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$649K -$350K -117% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$299K -$622K -193% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $323K -$3.19M -90.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $3.51M +$3.49M +13415% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
2017 $26K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.